These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27044740)

  • 1. The Carbohydrate-linked Phosphorylcholine of the Parasitic Nematode Product ES-62 Modulates Complement Activation.
    Ahmed UK; Maller NC; Iqbal AJ; Al-Riyami L; Harnett W; Raynes JG
    J Biol Chem; 2016 May; 291(22):11939-53. PubMed ID: 27044740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of iodine and thiol-blocking reagents on complement component C2 and on the assembly of the classical-pathway C3 convertase.
    Kerr MA; Parkes C
    Biochem J; 1984 Apr; 219(2):391-9. PubMed ID: 6611150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular interactions between MASP-2, C4, and C2 and their activation fragments leading to complement activation via the lectin pathway.
    Wallis R; Dodds AW; Mitchell DA; Sim RB; Reid KB; Schwaeble WJ
    J Biol Chem; 2007 Mar; 282(11):7844-51. PubMed ID: 17204478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of human C4 to C-reactive protein-pneumococcal C-polysaccharide complexes during activation of the classical complement pathway.
    Volanakis JE; Narkates AJ
    Mol Immunol; 1983 Nov; 20(11):1201-7. PubMed ID: 6558418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the site of C4 deposition upon complement activation via the mannan-binding lectin pathway or the classical pathway.
    Møller-Kristensen M; Thiel S; Hansen AG; Jensenius JC
    Scand J Immunol; 2003 Jun; 57(6):556-61. PubMed ID: 12791093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphocholine and the polycation-binding sites on rabbit C-reactive protein are structurally and functionally distinct.
    Black S; Agrawal A; Samols D
    Mol Immunol; 2003 Jun; 39(16):1045-54. PubMed ID: 12749911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
    Gigli I; Sorvillo J; Mecarelli-Halbwachs L; Leibowitch J
    J Exp Med; 1981 Jul; 154(1):1-12. PubMed ID: 7019379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of complement component C5: comparison of C5 convertases of the lectin pathway and the classical pathway of complement.
    Rawal N; Rajagopalan R; Salvi VP
    J Biol Chem; 2008 Mar; 283(12):7853-63. PubMed ID: 18204047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.
    Nagasawa S; Stroud RM
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2998-3001. PubMed ID: 70787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2.
    Inal JM; Schifferli JA
    J Immunol; 2002 May; 168(10):5213-21. PubMed ID: 11994478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of complement activation by natural sulfated polysaccharides (fucans) from brown seaweed.
    Blondin C; Fischer E; Boisson-Vidal C; Kazatchkine MD; Jozefonvicz J
    Mol Immunol; 1994 Mar; 31(4):247-53. PubMed ID: 7908118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
    Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K
    J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3 nephritic factor stabilization of the classic C3 convertase: a role for C2 in C3 nephritic factor activity.
    McLean RH; Nilson SH
    Proc Soc Exp Biol Med; 1979 Jul; 161(3):358-63. PubMed ID: 461464
    [No Abstract]   [Full Text] [Related]  

  • 15. Purification and characterization of the C3 convertase of the classical pathway of human complement system by size exclusion high-performance liquid chromatography.
    Nagasawa S; Kobayashi C; Maki-Suzuki T; Yamashita N; Koyama J
    J Biochem; 1985 Feb; 97(2):493-9. PubMed ID: 3874204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aspirin on the complement system in vitro.
    Hänsch GM; Voigtländer V; Rother U
    Int Arch Allergy Appl Immunol; 1980; 61(2):150-8. PubMed ID: 7351347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MASP-2, the C3 convertase generating protease of the MBLectin complement activating pathway.
    Vorup-Jensen T; Jensenius JC; Thiel S
    Immunobiology; 1998 Aug; 199(2):348-57. PubMed ID: 9777418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
    Saint-Remy JM
    Eur J Immunol; 1984 Mar; 14(3):254-9. PubMed ID: 6608450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.
    Fujita T; Inoue T; Ogawa K; Iida K; Tamura N
    J Exp Med; 1987 Nov; 166(5):1221-8. PubMed ID: 2445886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C2 by-pass: Cross-talk between the complement classical and alternative pathways.
    Laich A; Patel H; Zarantonello A; Sim RB; Inal JM
    Immunobiology; 2022 May; 227(3):152225. PubMed ID: 35567980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.